Mesoblast MSCs Quell Peds GvHD; On Road to FDA Approval?
Graft-versus-host disease (GVHD) is counterintuitive In the weeks and months following a transplant, a major concern is the recipient’s immune system rejecting the “foreign” biological material. But in GVHD, the opposite happens: transplanted tissue unleashes a horde of T cells that spark a cascade of inflammation, within 100 days. Typically, GVHD follows a bone marrow […]
Mesoblast MSCs Quell Peds GvHD; On Road to FDA Approval? Read More »
